(HOMB) Home BancShares - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4368932004
Stock:
Total Rating 36
Risk 78
Buy Signal 0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 26.7% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.00 |
| Alpha | -12.88 |
| Character TTM | |
|---|---|
| Beta | 0.735 |
| Beta Downside | 1.074 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.45% |
| CAGR/Max DD | 0.42 |
EPS (Earnings per Share)
Revenue
Description: HOMB Home BancShares
Home Bancshares, Inc. (Conway, AR) operates as the bank holding company for Centennial Bank that provides commercial and retail banking, and related financial services to businesses, real estate developers and investors, individuals, and municipalities in the United States. The company offers checking, savings, and money market accounts, as well as certificates of deposit. It also provides non-farm/non-residential real estate, construction/land development, residential mortgage, consumer, agricultural, and commercial and industrial loans. In addition, the company offers internet and mobile banking, voice response information, cash management, overdraft protection, direct deposit, and automatic account transfer services, as well as safe deposit boxes and the United States savings bonds. Further, it writes policies for commercial and personal lines of business, including insurance for property, casualty, life, health, and employee benefits. The company operates through branches in Arkansas, Florida, South Alabama, Texas, and New York City. Home Bancshares, Inc. (Conway, AR) was founded in 1903 and is headquartered in Conway, Arkansas.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 475.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.60 > 1.0 |
| NWC/Revenue: -1052 % < 20% (prev -1001 %; Δ -51.19% < -1%) |
| CFO/TA 0.01 > 3% & CFO 310.6m > Net Income 475.4m |
| Net Debt (265.0m) to EBITDA (617.6m): 0.43 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (197.7m) vs 12m ago -0.66% < -2% |
| Gross Margin: 77.30% > 18% (prev 0.66%; Δ 7664 % > 0.5%) |
| Asset Turnover: 6.06% > 50% (prev 6.46%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 1.10 > 6 (EBITDA TTM 617.6m / Interest Expense TTM 408.8m) |
Altman Z'' -3.57
| A: -0.63 (Total Current Assets 3.11b - Total Current Liabilities 17.57b) / Total Assets 22.88b |
| B: 0.10 (Retained Earnings 2.26b / Total Assets 22.88b) |
| C: 0.02 (EBIT TTM 448.0m / Avg Total Assets 22.69b) |
| D: 0.11 (Book Value of Equity 2.09b / Total Liabilities 18.59b) |
| Altman-Z'' Score: -3.57 = D |
Beneish M
| DSRI: none (Receivables none/120.1m, Revenue 1.37b/1.45b) |
| GMI: 0.85 (GM 77.30% / 65.61%) |
| AQI: 0.99 (AQ_t 0.85 / AQ_t-1 0.86) |
| SGI: 0.95 (Revenue 1.37b / 1.45b) |
| TATA: 0.01 (NI 475.4m - CFO 310.6m) / TA 22.88b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of HOMB shares?
As of February 27, 2026, the stock is trading at USD 28.65 with a total of 1,000,011 shares traded.
Over the past week, the price has changed by -1.10%, over one month by +1.87%, over three months by +3.17% and over the past year by +1.34%.
Over the past week, the price has changed by -1.10%, over one month by +1.87%, over three months by +3.17% and over the past year by +1.34%.
Is HOMB a buy, sell or hold?
Home BancShares has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy HOMB.
- StrongBuy: 3
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HOMB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.4 | 16.5% |
| Analysts Target Price | 33.4 | 16.5% |
HOMB Fundamental Data Overview February 21, 2026
P/E Trailing = 12.4213
P/E Forward = 11.7371
P/S = 5.3665
P/B = 1.3436
P/EG = 3.72
Revenue TTM = 1.37b USD
EBIT TTM = 448.0m USD
EBITDA TTM = 617.6m USD
Long Term Debt = 729.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 155.8m USD (from shortTermDebt, last quarter)
Debt = 935.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 265.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.57b USD (5.74b + Debt 935.3m - CCE 3.11b)
Interest Coverage Ratio = 1.10 (Ebit TTM 448.0m / Interest Expense TTM 408.8m)
EV/FCF = 12.19x (Enterprise Value 3.57b / FCF TTM 292.8m)
FCF Yield = 8.21% (FCF TTM 292.8m / Enterprise Value 3.57b)
FCF Margin = 21.30% (FCF TTM 292.8m / Revenue TTM 1.37b)
Net Margin = 34.59% (Net Income TTM 475.4m / Revenue TTM 1.37b)
Gross Margin = 77.30% ((Revenue TTM 1.37b - Cost of Revenue TTM 312.0m) / Revenue TTM)
Gross Margin QoQ = 71.55% (prev none%)
Tobins Q-Ratio = 0.16 (Enterprise Value 3.57b / Total Assets 22.88b)
Interest Expense / Debt = 12.23% (Interest Expense 114.4m / Debt 935.3m)
Taxrate = 22.89% (35.1m / 153.3m)
NOPAT = 345.4m (EBIT 448.0m * (1 - 22.89%))
Current Ratio = 0.18 (Total Current Assets 3.11b / Total Current Liabilities 17.57b)
Debt / Equity = 0.22 (Debt 935.3m / totalStockholderEquity, last quarter 4.30b)
Debt / EBITDA = 0.43 (Net Debt 265.0m / EBITDA 617.6m)
Debt / FCF = 0.91 (Net Debt 265.0m / FCF TTM 292.8m)
Total Stockholder Equity = 4.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.10% (Net Income 475.4m / Total Assets 22.88b)
RoE = 11.43% (Net Income TTM 475.4m / Total Stockholder Equity 4.16b)
RoCE = 9.16% (EBIT 448.0m / Capital Employed (Equity 4.16b + L.T.Debt 729.1m))
RoIC = 6.82% (NOPAT 345.4m / Invested Capital 5.07b)
WACC = 8.73% (E(5.74b)/V(6.68b) * Re(8.62%) + D(935.3m)/V(6.68b) * Rd(12.23%) * (1-Tc(0.23)))
Discount Rate = 8.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.06%
[DCF] Terminal Value 75.72% ; FCFF base≈344.5m ; Y1≈350.3m ; Y5≈383.4m
[DCF] Fair Price = 28.53 (EV 5.88b - Net Debt 265.0m = Equity 5.61b / Shares 196.7m; r=8.73% [WACC]; 5y FCF grow 1.43% → 2.90% )
EPS Correlation: 67.17 | EPS CAGR: 13.76% | SUE: 0.0 | # QB: 0
Revenue Correlation: 63.42 | Revenue CAGR: 22.88% | SUE: 2.09 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.59 | Chg7d=-0.000 | Chg30d=+0.009 | Revisions Net=+3 | Analysts=9
EPS current Year (2026-12-31): EPS=2.51 | Chg7d=-0.000 | Chg30d=+0.049 | Revisions Net=+2 | Growth EPS=+6.9% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=2.64 | Chg7d=-0.004 | Chg30d=+0.051 | Revisions Net=+1 | Growth EPS=+5.2% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 8.6% - Earnings Yield 8.1%)
[Growth] Growth Spread = +3.8% (Analyst 4.4% - Implied 0.6%)
P/E Forward = 11.7371
P/S = 5.3665
P/B = 1.3436
P/EG = 3.72
Revenue TTM = 1.37b USD
EBIT TTM = 448.0m USD
EBITDA TTM = 617.6m USD
Long Term Debt = 729.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 155.8m USD (from shortTermDebt, last quarter)
Debt = 935.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 265.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.57b USD (5.74b + Debt 935.3m - CCE 3.11b)
Interest Coverage Ratio = 1.10 (Ebit TTM 448.0m / Interest Expense TTM 408.8m)
EV/FCF = 12.19x (Enterprise Value 3.57b / FCF TTM 292.8m)
FCF Yield = 8.21% (FCF TTM 292.8m / Enterprise Value 3.57b)
FCF Margin = 21.30% (FCF TTM 292.8m / Revenue TTM 1.37b)
Net Margin = 34.59% (Net Income TTM 475.4m / Revenue TTM 1.37b)
Gross Margin = 77.30% ((Revenue TTM 1.37b - Cost of Revenue TTM 312.0m) / Revenue TTM)
Gross Margin QoQ = 71.55% (prev none%)
Tobins Q-Ratio = 0.16 (Enterprise Value 3.57b / Total Assets 22.88b)
Interest Expense / Debt = 12.23% (Interest Expense 114.4m / Debt 935.3m)
Taxrate = 22.89% (35.1m / 153.3m)
NOPAT = 345.4m (EBIT 448.0m * (1 - 22.89%))
Current Ratio = 0.18 (Total Current Assets 3.11b / Total Current Liabilities 17.57b)
Debt / Equity = 0.22 (Debt 935.3m / totalStockholderEquity, last quarter 4.30b)
Debt / EBITDA = 0.43 (Net Debt 265.0m / EBITDA 617.6m)
Debt / FCF = 0.91 (Net Debt 265.0m / FCF TTM 292.8m)
Total Stockholder Equity = 4.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.10% (Net Income 475.4m / Total Assets 22.88b)
RoE = 11.43% (Net Income TTM 475.4m / Total Stockholder Equity 4.16b)
RoCE = 9.16% (EBIT 448.0m / Capital Employed (Equity 4.16b + L.T.Debt 729.1m))
RoIC = 6.82% (NOPAT 345.4m / Invested Capital 5.07b)
WACC = 8.73% (E(5.74b)/V(6.68b) * Re(8.62%) + D(935.3m)/V(6.68b) * Rd(12.23%) * (1-Tc(0.23)))
Discount Rate = 8.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.06%
[DCF] Terminal Value 75.72% ; FCFF base≈344.5m ; Y1≈350.3m ; Y5≈383.4m
[DCF] Fair Price = 28.53 (EV 5.88b - Net Debt 265.0m = Equity 5.61b / Shares 196.7m; r=8.73% [WACC]; 5y FCF grow 1.43% → 2.90% )
EPS Correlation: 67.17 | EPS CAGR: 13.76% | SUE: 0.0 | # QB: 0
Revenue Correlation: 63.42 | Revenue CAGR: 22.88% | SUE: 2.09 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.59 | Chg7d=-0.000 | Chg30d=+0.009 | Revisions Net=+3 | Analysts=9
EPS current Year (2026-12-31): EPS=2.51 | Chg7d=-0.000 | Chg30d=+0.049 | Revisions Net=+2 | Growth EPS=+6.9% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=2.64 | Chg7d=-0.004 | Chg30d=+0.051 | Revisions Net=+1 | Growth EPS=+5.2% | Growth Revenue=+5.1%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.6% (Discount Rate 8.6% - Earnings Yield 8.1%)
[Growth] Growth Spread = +3.8% (Analyst 4.4% - Implied 0.6%)